Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

NCT00170209 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

844

Enrollment

OTHER

Sponsor class

Conditions

Latent Tuberculosis Infection

Interventions

DRUG: Isoniazid
DRUG: Rifampin

Sponsor

McGill University

Collaborators

[object Object]